Bio-Fd&C

251120 · KOSDAQ · ₩251120 · 바이오에프디엔씨

₩9,140▼ ₩60 (0.65%)End-of-day · Oct 30, 2026 · End-of-day prices.
Trade
Alert me

Income statement

20252024202320222021
Revenue₩19B₩16B₩16B₩16B₩12B
Cost of sales₩6.3B₩4.9B₩4.6B₩4.9B₩4.8B
Gross profit₩13B₩11B₩11B₩11B₩7.1B
Operating income₩6.3B₩4.9B₩5B₩4.9B₩3.1B
Net income₩6.7B₩4.5B₩5.6B₩4.3B₩2.9B
Net income to shareholders₩6.7B₩4.5B₩5.6B₩4.3B₩2.9B

Balance sheet

20252024202320222021
Total assets₩73B₩67B₩63B₩59B₩23B
Current assets₩58B₩51B₩46B₩45B₩9.2B
Cash and equivalents₩11B₩7.7B₩12B₩11B₩5B
Total liabilities₩3.7B₩4.2B₩4.2B₩6.1B₩7.2B
Current liabilities₩3.4B₩4B₩4.1B₩6B₩6.8B
Borrowings₩100M₩1.2B₩1.2B₩3.4B₩3.8B
Total equity₩70B₩63B₩59B₩53B₩16B
Shareholders' equity₩70B₩63B₩59B₩53B₩16B

Cash flow

20252024202320222021
Cash from operations₩7.3B₩6B₩6B₩5.6B₩3.7B
Capital spending₩974M₩1.3B₩2B₩152M₩7B
Free cash flow₩6.3B₩4.8B₩4.1B₩5.4B−₩3.3B

Consolidated where available. Amounts in won.

Also known as: Bio-Fd&C / 바이오에프디엔씨 / 251120 / KRX:251120

Source: KRX statistical information